The interaction of corticosteroids and antimicrobial agents used in topical therapy.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002701:Chloramphenicol / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005672:Fusidic Acid / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D006854:Hydrocortisone; D007093:Imidazoles / Q000494:pharmacology; D008775:Methylprednisolone / Q000494:pharmacology; D010866:Natamycin / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009761:Nystatin / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010118:Oxytetracycline / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D014222:Triamcinolone Acetonide / Q000494:pharmacology; D014449:Tyrothricin / Q000494:pharmacology; D015003:Yeasts / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D005839:Gentamicins; D005938:Glucocorticoids; D007093:Imidazoles; D011113:Polymyxins; D005446:Fluocinolone Acetonide; D009761:Nystatin; D014449:Tyrothricin; D005672:Fusidic Acid; D002701:Chloramphenicol; D010866:Natamycin; D011239:Prednisolone; D014222:Triamcinolone Acetonide; D009355:Neomycin; D006854:Hydrocortisone; D010118:Oxytetracycline; D008775:Methylprednisolone